Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Frey

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Pediatric Infectious Disease Journal|June 22, 2002
Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group BEdwin L Anderson, Sharon Frey, Kathy Geldmacher, et al.
Gastroenterology|December 7, 2019
Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine DevelopmentFang Chen, Kenna Nagy, Deborah Chavez, et al.
Vaccine|December 3, 2014
Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccineAarthi Sundararajan, Mark Y Sangster, Sharon Frey, et al.
Journal of the National Medical Association|January 11, 2022
Effects of race on the outcome of COVID-19 in hospitalized patientsGetahun Abate, Aniruddh Kapoor, Edward Charbek, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2022
Universal hepatitis B vaccination in adults aged 19-59 years: Updated recommendations of the advisory committee on immunization practices-United States, 2022Mark K Weng, Mona Doshani, Mohammed A Khan, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022Mark K Weng, Mona Doshani, Mohammed A Khan, et al.
The Journal of Infectious Diseases|February 26, 2015
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) VaccinePatricia L Winokur, Shital M Patel, Rebecca Brady, et al.
The Journal of Infectious Diseases|September 2, 2005
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjectsPaul A Goepfert, Helen Horton, M Juliana McElrath, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2022
The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to ActionErin M Scherer, Martin Backer, Karen Carvajal, et al.
Vaccine|October 20, 2006
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersPaul A Goepfert, Georgia D Tomaras, Helen Horton, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Pediatric Infectious Disease Journal|June 22, 2002
Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group BEdwin L Anderson, Sharon Frey, Kathy Geldmacher, et al.
Gastroenterology|December 7, 2019
Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine DevelopmentFang Chen, Kenna Nagy, Deborah Chavez, et al.
Vaccine|December 3, 2014
Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccineAarthi Sundararajan, Mark Y Sangster, Sharon Frey, et al.
Journal of the National Medical Association|January 11, 2022
Effects of race on the outcome of COVID-19 in hospitalized patientsGetahun Abate, Aniruddh Kapoor, Edward Charbek, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2022
Universal hepatitis B vaccination in adults aged 19-59 years: Updated recommendations of the advisory committee on immunization practices-United States, 2022Mark K Weng, Mona Doshani, Mohammed A Khan, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022Mark K Weng, Mona Doshani, Mohammed A Khan, et al.
The Journal of Infectious Diseases|February 26, 2015
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) VaccinePatricia L Winokur, Shital M Patel, Rebecca Brady, et al.
The Journal of Infectious Diseases|September 2, 2005
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjectsPaul A Goepfert, Helen Horton, M Juliana McElrath, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2022
The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to ActionErin M Scherer, Martin Backer, Karen Carvajal, et al.
Vaccine|October 20, 2006
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersPaul A Goepfert, Georgia D Tomaras, Helen Horton, et al.
Pageof 3